[Federal Register Volume 66, Number 201 (Wednesday, October 17, 2001)]
[Notices]
[Page 52774]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-25998]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 00E-1250]


Determination of Regulatory Review Period for Purposes of Patent 
Extension; Synercid; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of September 21, 2001 (66 FR 
486920). The document determined the regulatory review period for 
Synercid and published the notice of that determination as required by 
law. The document published with an inadvertent error. This document 
corrects that error.

DATES:  October 17, 2001.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, 
Planning, and Legislation (HF-27), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-7010.

SUPPLEMENTARY INFORMATION: In FR Doc. 01-23703, appearing on page 48690 
in the Federal Register of Friday, September 21, 2001, the following 
correction is made: On page 48690, in the second column, ``Docket No. 
01E-1250]'' is corrected to read ``[Docket No. 00E-1250]''.

    Dated: October 10, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 01-25998 Filed 10-16-01; 8:45 am]
BILLING CODE 4160-01-S